(E)-2-(2,6-Dichloro-phen-yl)-2-(phenyl-imino)acetamide

Area of Science:

• Medicinal Chemistry
• Crystallography
• Organic Synthesis

Background:

• The development of novel inhibitors for human immunodeficiency virus type 1 (HIV-1) is crucial for public health.
• Understanding the structural properties of synthetic precursors can guide the design of more effective drugs.
• The title compound, C(14)H(10)Cl(2)N(2)O, serves as a key intermediate in the synthesis of potential HIV-1 inhibitors.

Purpose of the Study:

• To elucidate the crystal structure of the title compound, C(14)H(10)Cl(2)N(2)O.
• To analyze the molecular conformation and intermolecular interactions within the crystal lattice.
• To provide structural insights relevant to its role as a precursor for HIV-1 inhibitors.

Main Methods:

• Single-crystal X-ray diffraction was employed to determine the three-dimensional structure.
• Analysis of bond lengths, bond angles, and dihedral angles.
• Identification and characterization of intermolecular interactions, including hydrogen bonds and C-H interactions.

Main Results:

• The crystal structure reveals a dihedral angle of 69.4(1)° between the 2,6-dichlorophenyl ring and the phenyl ring.
• Molecules form centrosymmetric dimers through N-H⋯O hydrogen bonds, adopting an R(2)(2)(8) motif.
• Intermolecular C-H⋯O and C-H⋯π interactions further stabilize the crystal packing.

Conclusions:

• The determined crystal structure provides a detailed molecular blueprint of the HIV-1 inhibitor precursor.
• The observed hydrogen bonding and other non-covalent interactions are critical for understanding molecular assembly and stability.
• This structural information can inform future drug design and optimization strategies for HIV-1 therapies.